Dutch Healthcare Authority has published key features of the DRG package for 2020 (RZ20a)

24

Jan 2019

Dutch Healthcare Authority (NZa) has released key features of the DRG package for 2020, including complex chronic lung failure, stem cell transplant care and indexation of DRG tariffs.

Many diagnoses that occur in complex chronic lung failure have been added. The change for complex chronic lung failure is a part of the project that will start in 2021. Before 2021, the NZa will investigate whether adjustments should be made to the DRG product structure and tariffs.

In the aftercare phase for stem cell transplant care, a distinction has been made between adults and children. In addition, new healthcare activities are introduced for the situation when a patient is admitted for longer than the transplant phase.

The DRG tariffs for 2020 will be indexed. However, there is an exception for some care services. NZa is currently investigating how they can improve the tariff decisions via consultations with parties about this. A number of proposals that are now being discussed:

  • The (partial) standardization of cost price calculations
  • The more intensive involvement of care-related knowledge in the assessment of cost prices
  • The more detailed control of the quality of cost prices

The schedule with the most important milestones for the DRG package 2020 can be found here.

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more